Be a Smart Investor
Wednesday, April 5, 2017
Paratek Pharmaceuticals Inc. (PRTK) Surged To A New High On Study Results
Paratek Pharmaceuticals Inc. (PRTK) announced after the bell Monday that its Phase 3 study of omadacycline met its primary endpoint.
from RTT - Before the Bell http://ift.tt/2oC5OEi
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment